Wells Fargo & Company Altamira Therapeutics Ltd. Call Options Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Altamira Therapeutics Ltd.

EARS Quotes by TradingView
  • Ticker EARS
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,869,600
  • Market Cap $39.2M
More about EARS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email